Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Accelerated Approval: US FDA Should Explain Why An Ongoing Trial Is Not Required
Feb 02 2023
•
By
Sue Sutter
To keep skepticism from bubbling up, FDA should explain why it didn't require a trial be underway at the time of approval. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Review Pathways
More from Pathways & Standards